JOHN JOHNSON - 01 Oct 2021 Form 4 Insider Report for Strongbridge Biopharma plc

Role
Chief Executive Officer, Director
Signature
/s/ Judith Goldberg, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Oct 2021
Net transactions value
-$689,828
Form type
4
Filing time
05 Oct 2021, 19:24:45 UTC
Previous filing
21 Jul 2021
Next filing
08 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SBBP Ordinary Shares Tax liability $689,828 -334,868 -35% $2.06 610,092 01 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy taxes payable in connection with the vesting of previously awarded restricted stock units.